 | Up a level |
Godoy, Lucas C; Neal, Matthew D; Goligher, Ewan C; Cushman, Mary; Houston, Brett L; Bradbury, Charlotte A; McQuilten, Zoe K; Tritschler, Tobias; Kahn, Susan R; Berry, Lindsay R; Lorenzi, Elizabeth; Jensen, Tom; Higgins, Alisa M; Kornblith, Lucy Z; Berger, Jeffrey S; Gong, Michelle N; Paul, Jonathan D; Castellucci, Lana A; Le Gal, Grégoire; Lother, Sylvain A; ... (2024). Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19. JACC. Advances., 3(100780) Elsevier 10.1016/j.jacadv.2023.100780
Nguyen, Dan D; Spertus, John A; Alexander, Karen P; Newman, Jonathan D; Dodson, John A; Jones, Philip G; Stevens, Susanna R; O'Brien, Sean M; Gamma, Reto; Perna, Gian P; Garg, Pallav; Vitola, João V; Chow, Benjamin J W; Vertes, Andras; White, Harvey D; Smanio, Paola E P; Senior, Roxy; Held, Claes; Li, Jianghao; Boden, William E; ... (2023). Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial. Journal of the American College of Cardiology, 81(17), pp. 1697-1709. Elsevier 10.1016/j.jacc.2023.02.048
Lawler, Patrick R; Goligher, Ewan C; Berger, Jeffrey S; Neal, Matthew D; McVerry, Bryan J; Nicolau, Jose C; Gong, Michelle N; Carrier, Marc; Rosenson, Robert S; Reynolds, Harmony R; Turgeon, Alexis F; Escobedo, Jorge; Huang, David T; Bradbury, Charlotte A; Houston, Brett L; Kornblith, Lucy Z; Kumar, Anand; Kahn, Susan R; Cushman, Mary; McQuilten, Zoe; ... (2021). Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. The New England journal of medicine, 385(9), pp. 790-802. Massachusetts Medical Society 10.1056/NEJMoa2105911
Goligher, Ewan C; Bradbury, Charlotte A; McVerry, Bryan J; Lawler, Patrick R; Berger, Jeffrey S; Gong, Michelle N; Carrier, Marc; Reynolds, Harmony R; Kumar, Anand; Turgeon, Alexis F; Kornblith, Lucy Z; Kahn, Susan R; Marshall, John C; Kim, Keri S; Houston, Brett L; Derde, Lennie P G; Cushman, Mary; Tritschler, Tobias; Angus, Derek C; Godoy, Lucas C; ... (2021). Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. The New England journal of medicine, 385(9), pp. 777-789. Massachusetts Medical Society 10.1056/NEJMoa2103417
